장마감
Log in Sign up
기업소개

What Does Novanta (NOVT) Do? - Stock Outlook, Earnings, Market Cap, Related Stocks, Headquarters Summary

2026년 6월 5일 갱신 · 최초 발행 2026년 4월 8일

Novanta (NOVT) is a US company that supplies precision optics, vision, and motion components for medical and advanced industrial equipment. Its earnings and stock price are tied to medical and automation demand, new orders, acquisition expansion, and margins, and it is a precision instruments name characterized by high-value components integrated into equipment and high margins.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

🏢 What kind of company is Novanta?

Novanta (NOVT) is a US-based technology company that supplies precision optics, vision, and motion components used in medical and advanced industrial equipment. It is a components supplier that delivers core precision parts—laser and optical scanning, precision motion control, and machine vision—to medical and industrial equipment manufacturers.

Its core business is the design, production, and sale of precision components such as laser and optical scanning, precision motion control, and machine vision. These are integrated as core components in medical equipment (surgical and diagnostic) and advanced industrial equipment manufacturers, and as high-value components deeply embedded in equipment, the business carries high margins and recurring demand. Its earnings are driven by medical and automation demand, new orders, and acquisitions.

💰 How does Novanta make money?

Business SegmentRevenue ShareDescription
Medical SolutionsCore BusinessPrecision components for surgical, diagnostic, and other medical equipment
Advanced IndustrialCore BusinessComponents for laser, automation, and other industrial equipment
Acquisition ExpansionGrowth DriverProduct and market expansion through acquisitions

Novanta's revenue is composed of precision components for medical equipment and components for advanced industrial equipment. The business is exposed to structural growth in medical (surgical and diagnostic) and advanced industrial end markets such as automation and lasers, and as high-value components deeply integrated into equipment, it offers high margins and recurring demand. New equipment adoption and product and market expansion through acquisitions serve as growth drivers, and its earnings are driven by medical and automation demand and new orders.

📐 Novanta Market Cap and Company Size

Its market capitalization stands at $5.1B and its employee headcount is 3,000명.

Novanta is a mid- to large-cap precision instruments company by market cap, with a differentiated position in precision optics and motion components for medical and advanced industrial applications. It is compared within the technology sector alongside peer precision components and instrumentation companies such as MKSI and COHR, while connecting to precision instruments name TDY and instrumentation name KEYS in terms of the precision instruments and components ecosystem. Leveraging high-margin cash generation, the company pursues expansion through acquisitions.

📈 Novanta Outlook and Stock Price Trends

📊 최근 1년 주가흐름
🎯 애널리스트 컨센서스
2.0
매도 보유 적극 매수
목표가 $175 +22.8% 현재 $143
📏 52주 가격 범위
$143
최저 $98 최고 $172
최저 대비 +45.06% 최고 대비 -17.05%

Over the medium to long term, the drivers are medical equipment demand, growth in advanced industrial end markets such as automation and lasers, new equipment adoption, and expansion through acquisitions. Medical and automation demand, new orders, and acquisition effects are the key variables at work. Over the short term, a slowdown in industrial automation investment and inventory adjustments in some end markets could weigh on revenue, while raw material and component costs and acquisition integration costs could affect margins. Medical equipment demand fluctuations are also a variable.

  • Medical equipment demand and advanced industrial automation growth
  • New equipment adoption and expansion of high-value components
  • Product and market expansion through acquisitions

⚔️ Novanta Key Competitive Strengths and Risks

Exposure to medical and automation growth, high margins from high-value precision components, and acquisition-driven growth are strengths, while the industrial automation cycle and acquisition integration and costs are key risks.

💪 Key Competitive Strengths

Growth Exposure
Exposed to structural growth in medical and advanced industrial end markets such as automation and lasers.
High-Value Components
High-value components deeply integrated into equipment, providing high margins and recurring demand.
Differentiated Technology
Differentiated technology and position in precision optics, vision, and motion.
Acquisition Growth
Pursues growth by broadening product lines and markets through acquisitions.

⚠️ Key Risks

Automation Cycle
A slowdown in industrial automation investment and inventory adjustments in some end markets could weigh on revenue.
Acquisition Integration
Integration costs and risks during expansion through acquisitions act as variables.
Cost and Demand Variability
Raw material and component costs and medical equipment demand fluctuations can affect margins and earnings.

🔄 Novanta Competitors and Related Stocks (Beneficiaries)

From a direct comparison standpoint, the company is benchmarked within the technology sector alongside precision components and instrumentation names such as MKSI and COHR. Related names include precision instruments name TDY and instrumentation name KEYS, which are grouped together in terms of the precision instruments and components ecosystem, and they tend to be affected by medical and industrial equipment demand and the automation cycle.

⚔️ 경쟁주
종목회사명가격등락시총PERPBRROE배당률
MKSIMKSIMKS Inc$297.11+1.3%$20.1B62.17.112.7%0.34%
COHRCoherent Corp$262.89+5.5%$51.4B125.54.85.07%0.02%
🔗 관련주 (수혜주)
종목회사명가격등락시총PERPBRROE배당률
TDYTeledyne Technologies Inc$655.57+1.0%$30.4B31.72.89.16%-
KEYSKeysight Technologies Inc$319.08+2.0%$54.5B52.68.618.17%-

✅ Novanta Investor Checklist

Key points to check when investing in Novanta. As a precision instruments name, medical and automation demand, new orders, acquisition expansion, and costs and margins are the key short- and medium-term variables.

CheckpointWhat to CheckCurrent Status
🏥 Medical DemandMedical equipment demand and new adoptionNeeds Monitoring
🤖 Automation DemandAdvanced industrial automation investmentTied to Cycle
🤝 Acquisition ExpansionProduct and market expansion through acquisitionsNeeds Monitoring
💵 MarginsShare of high-value components and marginsMonitor Continuously

A slowdown in industrial automation investment and inventory adjustments in some end markets could weigh on revenue. There are integration costs and risks during expansion through acquisitions, and raw material and component costs as well as medical equipment demand fluctuations can also act as factors affecting margins and earnings.

Novanta is a precision instruments company with a differentiated position in precision optics, vision, and motion components used in medical and advanced industrial equipment. Medical and automation demand, new orders, acquisition expansion, and margins are the key variables to watch, and a phased buying approach with a long-term perspective is recommended, weighing the strengths of growth exposure and high-value margins against the risks of the automation cycle and integration.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

이 글은 2026년 6월 5일 기준 정보입니다.

🎯 오늘의 AI 픽 5종목, 무료로 전부 공개합니다
숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다
오늘의 픽 보기 →